glucagon

(redirected from GlucaGen)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to GlucaGen: glucagon, Glucogen

glu·ca·gon

 (glo͞o′kə-gŏn′)
n.
A hormone produced by the pancreas that stimulates an increase in blood sugar levels, thus opposing the action of insulin.

[Probably gluc(o)- + Greek agōn, present participle of agein, to lead, drive; see ag- in Indo-European roots.]

glucagon

(ˈɡluːkəˌɡɒn; -ɡən)
n
(Biochemistry) a polypeptide hormone, produced in the pancreas by the islets of Langerhans, that stimulates the release of glucose into the blood. Compare insulin
[C20: from gluc(ose) + -agon, perhaps from Greek agein to lead]

glu•ca•gon

(ˈglu kəˌgɒn)

n.
a hormone secreted by the pancreas that acts in opposition to insulin in the regulation of blood glucose levels.
[1923]

glucagon

A hormone that breaks down glycogen to glucose. It is produced by the pancreatic islets.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.glucagon - a hormone secreted by the pancreas; stimulates increases in blood sugar levels in the blood (thus opposing the action of insulin)
endocrine, hormone, internal secretion - the secretion of an endocrine gland that is transmitted by the blood to the tissue on which it has a specific effect
Translations

glu·ca·gon

[MIM*138030]
n. glucagón, una de las hormonas segregadas por los Islotes de Langerhans de efecto antiinflamatorio, cuya función consiste en aumentar la concentración de glucosa en la sangre.

glucagon

n glucagón m
References in periodicals archive ?
Reportedly, Phase 2 clinical results indicated that dasiglucagon rapidly increases plasma glucose (PG) levels after insulin-induced hypoglycaemia, with a longer lasting and more pronounced PG increase with dasiglucagon compared to the active comparator, GlucaGen.
The new site will perform formulation, freeze-drying, filling and packaging of some of Novo's biopharma products, including NovoSeven, Norditropin, and GlucaGen.
The facility will cover formulation, freeze-drying, filling and packaging of a range of Novo Nordisk's biopharmaceuticals, including the haemophilia medicine NovoSeven, the growth hormone Norditropin and the glucagon product GlucaGen.
As part of its aggressive Medication Dedication program, Blue Cross and Blue Shield of North Carolina not only waived copayment for generics but also moved more than 40 drugs to treat chronic diseases, such as Glyset and GlucaGen for diabetes, from tier 3 to tier 2.